SI21447A - Sestavek pripravka, ki vsebuje kislinsko nestabilno fiziološko aktivno spojino in postopek priprave le-tega - Google Patents

Sestavek pripravka, ki vsebuje kislinsko nestabilno fiziološko aktivno spojino in postopek priprave le-tega Download PDF

Info

Publication number
SI21447A
SI21447A SI200220036A SI200220036A SI21447A SI 21447 A SI21447 A SI 21447A SI 200220036 A SI200220036 A SI 200220036A SI 200220036 A SI200220036 A SI 200220036A SI 21447 A SI21447 A SI 21447A
Authority
SI
Slovenia
Prior art keywords
composition
layer
water
physiologically active
insoluble polymer
Prior art date
Application number
SI200220036A
Other languages
English (en)
Slovenian (sl)
Inventor
Shigeru Aoki
Original Assignee
Eisai Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co. Ltd. filed Critical Eisai Co. Ltd.
Publication of SI21447A publication Critical patent/SI21447A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
SI200220036A 2001-11-21 2002-11-20 Sestavek pripravka, ki vsebuje kislinsko nestabilno fiziološko aktivno spojino in postopek priprave le-tega SI21447A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001356018 2001-11-21
PCT/JP2002/012132 WO2003043661A1 (fr) 2001-11-21 2002-11-20 Compositions de preparation contenant des composes actifs au plan physiologiques et instables aux acides et leur procede de production

Publications (1)

Publication Number Publication Date
SI21447A true SI21447A (sl) 2004-10-31

Family

ID=19167613

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200220036A SI21447A (sl) 2001-11-21 2002-11-20 Sestavek pripravka, ki vsebuje kislinsko nestabilno fiziološko aktivno spojino in postopek priprave le-tega

Country Status (25)

Country Link
EP (1) EP1454634A4 (ru)
JP (1) JP4540092B2 (ru)
KR (1) KR20050044545A (ru)
CN (2) CN101982199A (ru)
AP (1) AP1919A (ru)
AU (1) AU2002366029B2 (ru)
BR (1) BR0214372A (ru)
CA (1) CA2466726C (ru)
CO (1) CO5580800A2 (ru)
CR (1) CR7351A (ru)
EC (1) ECSP045110A (ru)
HU (1) HUP0402323A3 (ru)
IL (2) IL161983A0 (ru)
IS (1) IS7266A (ru)
MA (1) MA26346A1 (ru)
MX (1) MXPA04004775A (ru)
NO (1) NO20042563L (ru)
NZ (1) NZ532907A (ru)
RO (1) RO122395B1 (ru)
RU (1) RU2311906C2 (ru)
SI (1) SI21447A (ru)
TW (1) TWI302461B (ru)
UA (1) UA76256C2 (ru)
WO (1) WO2003043661A1 (ru)
ZA (1) ZA200403551B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
CN1938026A (zh) * 2004-03-26 2007-03-28 卫材R&D管理有限公司 控释制剂及其制造方法
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
CA2584957C (en) 2004-10-21 2015-08-25 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
CA2592605C (en) 2004-12-27 2010-12-07 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
WO2006123364A2 (en) * 2005-03-14 2006-11-23 Sun Pharmaceutical Industries Limited Oral drug delivery system providing a coating comprising both a cellulose and a methacrylic acid derivative
WO2006111853A2 (en) * 2005-04-18 2006-10-26 Aurobindo Pharma Limited Stable solid dosage forms of acid labile drug
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
WO2008062320A2 (en) 2006-10-06 2008-05-29 Eisai R&D Management Co., Ltd Extended release formulations of a proton pump inhibitor
WO2009069280A1 (ja) * 2007-11-27 2009-06-04 Ohara Pharmaceutical Co., Ltd. 造粒物の製造法
CN101822671A (zh) * 2009-03-06 2010-09-08 信谊药厂 雷贝拉唑组合物及其制备方法
WO2011067667A2 (en) 2009-12-02 2011-06-09 Eurand Pharmaceuticals Limited Fexofenadine microcapsules and compositions containing them
NZ605562A (en) * 2010-07-09 2013-11-29 Teijin Pharma Ltd Deuterated benzylbenzene derivatives and methods of use
JP2018184360A (ja) * 2017-04-25 2018-11-22 ニプロ株式会社 経口投与用の腸溶性徐放性製剤
KR102227486B1 (ko) * 2017-06-30 2021-03-12 롯데정밀화학 주식회사 프로톤 펌프 저해제를 포함하는 경구용 고형제제 조성물, 이를 포함하는 경구용 고형제제 및 그 제조방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
JPS5944311A (ja) * 1982-09-07 1984-03-12 Santen Pharmaceut Co Ltd 徐放性顆粒およびその製造法
ATE124864T1 (de) * 1989-03-10 1995-07-15 Yamanouchi Pharma Co Ltd Die wirkstoffabgabe steuerndes überzugsmaterial für lang wirksame formulierungen.
EP0447168A3 (en) * 1990-03-16 1993-01-07 Yamanouchi Pharmaceutical Co. Ltd. Long acting granular pharmaceutical composition
JPH0826977A (ja) * 1994-07-19 1996-01-30 Tanabe Seiyaku Co Ltd 溶出制御型経口製剤
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
ES2137862B1 (es) * 1997-07-31 2000-09-16 Intexim S A Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
WO1999053918A1 (fr) * 1998-04-20 1999-10-28 Eisai Co., Ltd. Compositions stabilisees contenant des composes du type benzimidazole
DK1736144T3 (en) * 1998-05-18 2015-12-07 Takeda Pharmaceutical Orally disintegrating tablets.
JP2001055322A (ja) * 1999-08-18 2001-02-27 Tanabe Seiyaku Co Ltd パルス放出型製剤
DK1222922T3 (da) * 1999-10-20 2007-12-03 Eisai R&D Man Co Ltd Fremgangsmåde til stabilisering af benzimidazolforbindelser
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems

Also Published As

Publication number Publication date
KR20050044545A (ko) 2005-05-12
TWI302461B (en) 2008-11-01
EP1454634A1 (en) 2004-09-08
CO5580800A2 (es) 2005-11-30
RU2004118495A (ru) 2005-03-20
NO20042563L (no) 2004-06-18
NZ532907A (en) 2007-05-31
AU2002366029B2 (en) 2008-01-31
CN101982199A (zh) 2011-03-02
WO2003043661A1 (fr) 2003-05-30
BR0214372A (pt) 2004-10-26
CN1589156A (zh) 2005-03-02
AU2002366029A1 (en) 2003-06-10
IS7266A (is) 2004-05-14
CA2466726A1 (en) 2003-05-30
UA76256C2 (en) 2006-07-17
RU2311906C2 (ru) 2007-12-10
MXPA04004775A (es) 2005-02-17
RO122395B1 (ro) 2009-05-29
AP1919A (en) 2008-11-13
AP2004003045A0 (en) 2004-06-30
JPWO2003043661A1 (ja) 2005-03-10
TW200300353A (en) 2003-06-01
EP1454634A4 (en) 2007-05-30
JP4540092B2 (ja) 2010-09-08
ECSP045110A (es) 2004-08-27
ZA200403551B (en) 2005-07-07
HUP0402323A3 (en) 2008-04-28
CR7351A (es) 2005-05-12
CA2466726C (en) 2011-02-22
MA26346A1 (fr) 2004-10-01
IL161983A0 (en) 2005-11-20
HUP0402323A2 (hu) 2005-02-28
IL161983A (en) 2009-11-18

Similar Documents

Publication Publication Date Title
DE69832621T2 (de) Neue pharmazeutische formulierungen mit kontrollierter freigabe von wirkstoffen
RU2375048C2 (ru) Фармацевтическая композиция с набухающим покрытием
SI21447A (sl) Sestavek pripravka, ki vsebuje kislinsko nestabilno fiziološko aktivno spojino in postopek priprave le-tega
SK281202B6 (sk) Spôsob prípravy orálneho farmaceutického prípravku
HU226580B1 (en) Pharmaceutical formulation comprising a 2-[[(2-pyridinyl)methyl]sulfinyl] benzimidazole having anti-ulcer activity and a process for the preparation of such formulation
IL136827A (en) Pharmaceutical dosage form for oral administration with prolonged release
BG64967B1 (bg) Метод за получаване на орален фармацевтичен препарат, включващ съединение с противоязвена активност
JPH09502740A (ja) プロトンポンプ抑制剤を含有する複数単位の製剤
US20080311204A1 (en) Stable oral formulation containing benzimidazole derivative
RU2259828C2 (ru) Способы стабилизации соединений на основе бензимидазола
CA2702356A1 (en) Pharmaceutical formulation comprising a proton pump inhibitor for the treatment of gastrointestinal conditions independent of food intake
PL200043B1 (pl) Mikrogranulki z omeprazolem, sposób wytwarzania i preparaty farmaceutyczne
EP2384746A2 (en) Dual release oral tablet compositions of dexlansoprazole
WO2005027876A1 (en) Pharmaceutical compositions of benzimidazole and processes for their preparation
AU2010317013A1 (en) Pharmaceutical solid dosage form
EP2384745A2 (en) Modified Release Pharmaceutical Compositions Of Dexlansoprazole
US20110045068A1 (en) Pharmaceutical formulations for the oral administration of ppi
US20050163846A1 (en) Preparation composition containing acid-unstable physiologically active compound, and process for producing same
US20050191353A1 (en) Process for manufacture of stable oral multiple unit pharmaceutical composition containing benzimidazoles
WO2004075881A1 (en) Stable pharmaceutical composition of rabeprazole and processes for their preparation
SI22571A (sl) Stabilen trden farmacevtski sestavek, ki obsega kandesartan ali njegove farmacevtsko sprejemljive oblike

Legal Events

Date Code Title Description
OO00 Grant of patent

Effective date: 20040803

IF Valid on the event date
SP73 Change of data on owner

Owner name: EISAI R& D MANAGEMENT CO., LTD.; JP

Effective date: 20070219

KO00 Lapse of patent

Effective date: 20120628